Study: NCT02257242

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 I.V. on Day 1 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 I.V. on Day 1 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 I.V. on Day 1 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 I.V. on Day 1 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 I.V. on Day 1 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m2 I.V. on Day 1 and 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome injection
Description: Dose per dose escalation protocol, I.V. on Day 2 of each cycle